Animal Model Market in Industry: Consumer Goods, Applications, Growth and Status 2024-2031

The global animal model market, valued at USD 2.41 billion in 2023, is expected to experience significant growth, reaching USD 4.20 billion by 2031. This growth reflects a compound annual growth rate (CAGR) of 7.2% during the forecast period from 2024 to 2031. Key drivers behind this expansion include increasing research activities in pharmaceutical and biotechnology sectors, where animal models play a pivotal role in understanding disease mechanisms, drug development, and safety testing.

Animal models are indispensable in advancing biomedical research by providing insights into complex diseases and evaluating therapeutic interventions before clinical trials. As the demand for personalized medicine and targeted therapies continues to rise, the importance of animal models in predicting human responses to treatments becomes more pronounced. Moreover, technological advancements in genetic engineering and imaging techniques are enhancing the utility and relevance of animal models, further fueling market growth.

The future of the animal model market is poised for innovation, with ongoing efforts to refine models, reduce variability, and improve translatability to human conditions. These advancements are crucial in addressing challenges in drug development and ensuring safer and more effective treatments for various diseases.

Get Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3789

Key Players

Major companies in the animal model market include:

• Charles River Laboratories International, Inc.
• Envigo Corporation (Now part of Labcorp)
• Taconic Biosciences, Inc.
• JANVIER LABS
• genOway S.A.
• Horizon Discovery Group plc
• Trans Genic Inc.
• Ingenious Targeting Laboratory, Inc.
• Harbour BioMed (formerly Harbour Antibodies BV)
• Crown Bioscience Inc.
• Other players

Market Analysis

The growth of the animal model market is driven by:

• Increasing Research in Biomedical and Pharmaceutical Fields: Demand for animal models in drug discovery and development.
• Technological Advancements: Development of genetically engineered animal models.
• Rising Prevalence of Chronic Diseases: Need for better understanding and treatment options.

Key Segments

By Type:

• Transgenic Models
• Knockout Models
• Hybrid/Congenic Models
• Inbred Models
• Outbred Models
• Others

By Application:

• Basic Research
• Drug Discovery and Development
• Toxicology
• Cancer Research
• Other Applications

By End User:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic and Research Institutions
• Other End Users

Regional Analysis

North America and Europe are anticipated to dominate the animal model market due to extensive research activities and well-established pharmaceutical industries. Asia Pacific is expected to witness significant growth, driven by increasing investments in biomedical research and development.

Key Takeaways

• The animal model market is experiencing steady growth, supported by advancements in genetic engineering and increasing demand for personalized medicine.
• Transgenic and knockout models are expected to remain prominent due to their utility in studying genetic mechanisms and disease pathways.
• Collaborations between pharmaceutical companies and research institutions are likely to drive innovation and market expansion.

About Us

SNS Insider is a leading market research and consulting agency providing comprehensive insights into global markets. We specialize in delivering accurate market data and strategic recommendations to our clients worldwide.

Other Related Reports

Cosmetic Dentistry Market Technology

Degenerative Disc Disease Treatment Market Technology

Dental Biomaterials Market Technology

Dental Bone Graft And Substitutes Market Technology

Contact Us

Akash Anand – Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: SNS Insider